Out-licensing: Parkinson´s Transdermal Patch

Latest: Watch here for details of new products and services.

About Us: Pharmalicensing - Partnering solutions for the life sciences
Our Products: Overview; Partnering Search; Company Profiling; Deal Negotiation; PL Intelligence; Reports; Comparison
PL Intelligence: Overview; Industry news; Deals review; Press releases; Articles
Case Studies: See what others think about our service
Newsletter: Partnering update; Key reports; Subscribe
Quick Links: Profile now; Register now; Profiled companies; Featured events; Industry news; PR Newswire; Jobs; Forums
Contact Pharmalicensing: Send an email; Call us: +44 1904 520460; Request a callback
RSS Feeds: Keep up to date

Pharmalicensing
is a division of
UTEK Europe Ltd

7-day transdermal patch for treatment of Parkinson´s disease

monoamine oxidase inhibitor

Labtec is developing a 7-day transdermal system with an well-estabilished drug for the treatment of Parkinson´s disease

Preclinical

undisclosed

Worldwide licensing rights available

Dr Ingo Lehrke
Managing Director; Business Development

Labtec GmbH

Labtec GmbH provides innovative Product Development and Manufacturing Services all over the world.

Are you looking for reports related to this particular subject. Our Reports section is the best place to start.

Industry sector: Pharmaceutical / Prescription
Therapeutic target: Central Nervous System / Neurodegenerative disorders / Parkinson's disease

Clients in focus...

Get the Flash Player to see this rotator.

Press releases: Pharmalicensing current industry press releases.